Literature DB >> 12805064

IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro.

Nuno L Alves1, Berend Hooibrink, Fernando A Arosa, René A W van Lier.   

Abstract

Recent studies in mice have shown that although interleukin 15 (IL-15) plays an important role in regulating homeostasis of memory CD8+ T cells, it has no apparent function in controlling homeostatic proliferation of naive T cells. We here assessed the influence of IL-15 on antigen-independent expansion and differentiation of human CD8+ T cells. Both naive and primed human T cells divided in response to IL-15. In this process, naive CD8+ T cells successively down-regulated CD45RA and CD28 but maintained CD27 expression. Concomitant with these phenotypic changes, naive cells acquired the ability to produce interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha), expressed perforin and granzyme B, and acquired cytotoxic properties. Primed CD8+ T cells, from both noncytotoxic (CD45RA-CD27+) and cytotoxic (CD45RA+CD27-) subsets, responded to IL-15 and yielded ample numbers of cytokine-secreting and cytotoxic effector cells. In summary, all human CD8+ T-cell subsets had the ability to respond to IL-15, which suggests a generic influence of this cytokine on CD8+ T-cell homeostasis in man.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805064     DOI: 10.1182/blood-2003-01-0183

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

Review 1.  The transcriptional control of the perforin locus.

Authors:  Matthew E Pipkin; Anjana Rao; Mathias G Lichtenheld
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy.

Authors:  M Montes; N Rufer; V Appay; S Reynard; M J Pittet; D E Speiser; P Guillaume; J-C Cerottini; P Romero; S Leyvraz
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

3.  Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.

Authors:  Claudia Wrzesinski; Chrystal M Paulos; Luca Gattinoni; Douglas C Palmer; Andrew Kaiser; Zhiya Yu; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

4.  Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.

Authors:  Thomas A Stoklasek; Kimberly S Schluns; Leo Lefrançois
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

5.  Interleukin-15 enhances T-cell responses by stimulation with dendritic cells.

Authors:  Yu Zhao; Ke Cheng; Yang Wu; Xing-Chen Peng; Ye Chen; Ben-Xu Tan; Jun Ge; Hang Dong; Meng Wei; Feng Gao; Jing-Mei Su; Jian-Mei Hou; Ji-Yan Liu
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

6.  4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells.

Authors:  Young-June Kim; Myung-Kwan Han; Hal E Broxmeyer
Journal:  Blood       Date:  2007-11-16       Impact factor: 22.113

7.  Immunologic reconstitution in 22q deletion (DiGeorge) syndrome.

Authors:  Sean A McGhee; Maria Garcia Lloret; E Richard Stiehm
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

8.  Red blood cells carry out T cell growth and survival bioactivities that are sensitive to cyclosporine A.

Authors:  Ricardo F Antunes; Cláudia Brandão; Gonçalo Carvalho; Cristina Girão; Fernando A Arosa
Journal:  Cell Mol Life Sci       Date:  2009-10       Impact factor: 9.261

9.  IL-21 preferentially enhances IL-15-mediated homeostatic proliferation of human CD28+ CD8 memory T cells throughout the adult age span.

Authors:  Huy Nguyen; Nan-ping Weng
Journal:  J Leukoc Biol       Date:  2009-10-01       Impact factor: 4.962

Review 10.  Memory CD8+ T cell differentiation in viral infection: a cell for all seasons.

Authors:  Henry Radziewicz; Luke Uebelhoer; Bertram Bengsch; Arash Grakoui
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.